Lukas Frischknecht

Expression of the Stem Cell Factor Nestin in Malignant Pleural Mesothelioma Is Associated with Poor Prognosis

R. Stahel, D. Korol, W. Weder, 2015, PloS one.

Dynamic changes of genomic and transcriptomic tumor diversity during melanoma progression

Christos M. Dimitrakopoulos, N. Beerenwinkel, C. Beisel, 2021, bioRxiv.

Importance of excision repair cross-complementation group 1 and ribonucleotide reductase M1 as prognostic biomarkers in malignant pleural mesothelioma treated with platinum-based induction chemotherapy followed by surgery.

H. Moch, B. Seifert, R. Stahel, 2015, The Journal of thoracic and cardiovascular surgery.

PI3K/mTOR Signaling in Mesothelioma Patients Treated with Induction Chemotherapy Followed by Extrapleural Pneumonectomy

H. Moch, B. Seifert, M. Tsao, 2014, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

The impact of pre-transplant donor specific antibodies on the outcome of kidney transplantation – Data from the Swiss transplant cohort study

I. Binet, Yun Deng, D. Sidler, 2022, Frontiers in Immunology.

BRAF inhibition sensitizes melanoma cells to α-amanitin via decreased RNA polymerase II assembly

M. Gstaiger, C. Britschgi, W. Krek, 2019, Scientific Reports.

Prognostic significance of Hif1-alpha and Glut1 expression in malignant pleural mesothelioma

Lukas Frischknecht, L. Frischknecht, 2018 .

The role of epigenetics and immunological imbalance in the etiopathogenesis of psoriasis and psoriatic arthritis

C. Selmi, M. Vecellio, Lukas Frischknecht, 2019, Therapeutic advances in musculoskeletal disease.

Colorectal cancer cells display chaperone dependency for the unconventional prefoldin URI1

C. Britschgi, W. Krek, K. Schrader, 2016, Oncotarget.

Donation type and the effect of pre-transplant donor specific antibodies – Data from the Swiss Transplant Cohort Study

I. Binet, D. Sidler, J. Villard, 2023, Frontiers in Immunology.